Langemeijer et al.[17] conducted SNP array–based genomic profiling and genomic sequencing in 102 individuals with MDS and identified acquired deletions and missense and nonsense mutations in the TET2 gene in 26% of these individuals. The gene discussed is TET2; the disease is myelodysplastic syndrome.